Bristol-Myers Squibb Company
Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibody

Abstract:

This disclosure provides combination therapy for treating a subject, such as a subject afflicted with a lung cancer, comprising administering to the subject an anti-fucosyl-GM1 antibody and an anti-CD137 antibody, or antigen-binding portions of either or both.